← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2013Last known activity
Mar 4, 2024
Timeline
2000s
- Jun 1, 2008
Rhizen Pharmaceuticals SA— Founded
Drugs by trial phase (8 distinct, 17 trials)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT06189209Lead sponsorPhase 2Mar 4, 2024
- NCT05239910Lead sponsorPhase 2Jan 31, 2023
- NCT05246384Lead sponsorPhase 1/Phase 2Jan 31, 2023
- NCT05021900Lead sponsorPhase 2Oct 13, 2021
- NCT05002868Lead sponsorPhase 1Oct 5, 2021
- NCT05007236Lead sponsorPhase 2Sep 20, 2021
- NCT04680429Lead sponsorPhase 1Dec 31, 2020
- NCT04204057Lead sponsorPhase 2Nov 28, 2019
- NCT03770000Lead sponsorPhase 1/Phase 2Mar 12, 2019
- NCT03711604Lead sponsorPhase 1/Phase 2Nov 28, 2018
- NCT03711578Lead sponsorPhase 2Nov 25, 2018
- NCT03471351Lead sponsorPhase 1/Phase 2Jul 18, 2018
- NCT03119467Lead sponsorPhase 1May 11, 2017
- NCT02958982Lead sponsorPhase 1/Phase 2Oct 1, 2016
- NCT02690727Lead sponsorPhase 1Feb 1, 2016
Details
- Founded
- La Chaux-de-Fonds, CH Jun 1, 2008
- Last known activity
- Mar 4, 2024